Figure 1.
Enrollment and outcomes in patients with decitabine treatment. Abbreviations: AML, acute myeloid leukemia; CAG, Cytarabine + Aclarubicin +G‐CSF; CR, complete remission; DAC, Decitabine; FLAG, Fludarabine + Cytarabine +G‐CSF; HAA/HAG, Homoharringtonine + Cytarabine +Aclarubicin/ Granulocyte Colony‐Stimulating Factor (G‐CSF); IA, Idarubicin + Cytarabine; MAE/IAE, Mitoxantrone/ Idarubicin (MA) + Cytarabine + Etoposide); MDS, myelodysplasia syndrome; PR, partial remission